Related Experiment Videos
[Myocardial uptake of 125I-BMIPP in rats treated with adriamycin]
Abstract:
The ability of 125I-BMIPP in assessing myocardial mitochondrial function was investigated in rats treated with adriamycin (ADR). Intraperitoneal administration of ADR (4 mg/kg) for 6 days significantly decreased a ratio of heart/body weight as compared with the control rats. The light and electron microscopic analysis showed that ADR produced histological damages mainly in the mitochondria with minimal changes in the myofibril and nucleus. In the study of mitochondrial respiratory function, oxygen consumption with adding ADP, respiratory control ratio and ADP/O ratio were significantly lower in ADR rats than control rats. While myocardial uptake of 201TlCl was not different between the two groups, the uptake of 125I-BMIPP corrected by blood counts was significantly reduced in ADR rats (3.1 +/- 0.4 vs. 2.3 +/- 0.8, p less than 0.05) and the reduction was mainly observed in the mitochondrial fraction. These results suggest that impairment of mitochondrial function by ADR produced a reduction in mitochondrial and consequently myocardial uptakes of 125I-BMIPP. The observation suggests that 125I-BMIPP myocardial scintigraphy could be a useful method for determining mitochondrial function in patients with myocardial diseases.
Insights
Adriamycin (ADR) damages rat heart mitochondria, reducing their function. 125I-BMIPP uptake reflects this mitochondrial dysfunction, suggesting its potential for diagnosing heart disease.
Area of Science:
- Cardiology
- Biochemistry
- Nuclear Medicine
Background:
- Adriamycin (ADR) is an anticancer drug known to cause cardiotoxicity.
- Myocardial mitochondrial dysfunction is a key mechanism in ADR-induced cardiotoxicity.
- Assessing mitochondrial function non-invasively is crucial for early diagnosis and management of heart disease.
Purpose of the Study:
- To investigate the utility of 125I-BMIPP scintigraphy in evaluating myocardial mitochondrial function in an ADR-induced rat model.
- To correlate 125I-BMIPP uptake with direct measures of mitochondrial respiratory function.
Main Methods:
- Rats were treated with adriamycin (ADR) to induce cardiotoxicity.
- Heart/body weight ratio, light and electron microscopy were assessed.
- Mitochondrial respiratory function (oxygen consumption, respiratory control ratio, ADP/O ratio) was measured.
- Myocardial uptake of 201TlCl and 125I-BMIPP was quantified and compared between ADR-treated and control rats.
Main Results:
- ADR treatment significantly decreased heart/body weight ratio and caused mitochondrial damage.
- ADR rats exhibited impaired mitochondrial respiratory function compared to controls.
- Myocardial uptake of 125I-BMIPP, but not 201TlCl, was significantly reduced in ADR rats.
- Reduced 125I-BMIPP uptake was primarily localized to the mitochondrial fraction.
Conclusions:
- ADR-induced impairment of myocardial mitochondrial function leads to decreased 125I-BMIPP uptake.
- 125I-BMIPP myocardial scintigraphy shows promise as a non-invasive method for assessing mitochondrial function in heart diseases.
- This technique could aid in the diagnosis and monitoring of patients with myocardial conditions.